Alpha BioMed
Weight Loss Blend - SLU-PP-332 (500mcg) / 5-Amino-1mq (50mg) / BPC-157 (125mcg) x 90 Tablets
Weight Loss Blend - SLU-PP-332 (500mcg) / 5-Amino-1mq (50mg) / BPC-157 (125mcg) x 90 Tablets
A provider account is required to view prices and to place orders. Click the button below to submit your application!
Have an account? Login here.
• Composition and format
Weight Loss Blend – SLU-PP-332 (500 mcg) / 5-Amino-1MQ (50 mg) / BPC-157 (125 mcg) is a fixed-combination research formulation supplied as solid-format tablets for controlled laboratory workflows. Each tablet contains 500 mcg of SLU-PP-332, 50 mg of 5-Amino-1MQ, and 125 mcg of BPC-157, with 90 tablets per container. The batch-specific Certificate of Analysis (COA) documents active-component identities, per-tablet content verification, physical characteristics, and relevant excipient information to support reproducibility, mass-balance calculations, and documentation control in research environments.
• Analytical verification
Each production lot is qualified at 99%+ purity by high-performance liquid chromatography, with compound identity confirmed by mass spectrometry. Independent third-party laboratories corroborate in-house analytical results to maintain traceable quality metrics appropriate for research use.
• Intended research use
Weight Loss Blend – SLU-PP-332 / 5-Amino-1MQ / BPC-157 is evaluated exclusively in controlled in-vitro systems investigating metabolic signaling pathways, mitochondrial activity models, cellular energy regulation, and peptide-associated cellular response mechanisms. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes in humans or animals.
• Research characteristics and applications
This multi-analyte formulation is characterized for use as a research tool in analytical and cell-based models examining interactions between mitochondrial signaling modulators, nicotinamide-related metabolic pathways, and peptide-mediated cellular signaling systems. In defined in-vitro environments, researchers employ the formulation to study metabolic pathway modulation, redox-associated energy processes, cellular stress-response signaling, and pathway cross-talk between small molecules and peptide components. Representative applications include assay development, comparative concentration-response profiling, time-course studies, and mechanistic investigations of cellular energy and signaling behavior strictly within laboratory settings.
• Manufacturing and documentation
Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. Certificates of Analysis, raw-material sourcing from vetted suppliers, and complete batch documentation are maintained to support institutional procurement review, traceability, and audit readiness.
Research Use Only (RUO) Statement
• For in-vitro research only
• Not for human or animal consumption
• Not for diagnostic or therapeutic use
